M. S. Ponomareva
Research Subjects
M. S. Ponomareva has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Evgenij G. Furman
Ye.A. Vagner Perm State Medical University
3 shared publications - Ekaterina A. Khuzina
Academician Ye.A. Wagner Perm State Medical University
2 shared publications - Yulia S. Alieva
Academician Ye.A. Wagner Perm State Medical University
2 shared publications A. M. Yarulina
Пермская государственная медицинская академия им. акад. Е.А.Вагнера Росздрава
1 shared publicationA. R. Abdullaev
Пермский государственный технический университет
1 shared publicationE.I. Kondratyeva
Medical and Genetic Research Centre named after Academician N.P. Bochkov Moscow RF
1 shared publication
Latest Publications
- 15 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 41 (1) , 59-72
Association of polymorphic variants of HHIP, ADRB2 and IL-33 genes with clinical manifestations of bronchial asthma in children
Objective. To study the association of polymorphic variants HHIP, ADRB2 and IL-33 genes with phenotypes of clinical course of bronchial asthma in children and effective treatment. Materials and methods. 90 patients aged from 5 to 17 with the diagnosis of bronchial asthma were included in the investigation. Diagnostic procedures were carried out in all the patients. They included the study of genetic polymorphism of HHIP, ADRB2 and IL-33 genes to establish the association with the clinical phenotypes, findings of laboratory and instrumental study determining the course of bronchial asthma and the degree of its control. Results. The study of polymorphism of HHIP, ADRB2 and IL-33 genes in children with bronchial asthma with different phenotypes of the disease revealed the association of genetic polymorphism with the severity of course of the disease as well as concomitant diseases. It was determined that allele T of genetic variant rs12504628 (TC) of HHIP gene reduces the risk of a severe course of BA. Its protective role in the development of drug allergy was also proved. Genotype AA of ADRB2 gene is associated with reduced risks of the development of congenital defects of the tracheobronchial tree in BA. Polymorphic variants in the 4th and 6th exon of IL-33 gene are more frequently associated with moderate and severe course of asthma and base substitution in the 4th and 6th exon are associated with the severe course. Conclusions. Associations of polymorphic variants of HHIP, ADRB2 and IL-33 genes with clinical manifestations of BA in children are determined in this study. They can be considered in a personalized monitoring of the patients and can help to control the disease totally.
- 15 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 41 (1) , 59-72
Association of polymorphic variants of HHIP, ADRB2 and IL-33 genes with clinical manifestations of bronchial asthma in children
Objective. To study the association of polymorphic variants HHIP, ADRB2 and IL-33 genes with phenotypes of clinical course of bronchial asthma in children and effective treatment. Materials and methods. 90 patients aged from 5 to 17 with the diagnosis of bronchial asthma were included in the investigation. Diagnostic procedures were carried out in all the patients. They included the study of genetic polymorphism of HHIP, ADRB2 and IL-33 genes to establish the association with the clinical phenotypes, findings of laboratory and instrumental study determining the course of bronchial asthma and the degree of its control. Results. The study of polymorphism of HHIP, ADRB2 and IL-33 genes in children with bronchial asthma with different phenotypes of the disease revealed the association of genetic polymorphism with the severity of course of the disease as well as concomitant diseases. It was determined that allele T of genetic variant rs12504628 (TC) of HHIP gene reduces the risk of a severe course of BA. Its protective role in the development of drug allergy was also proved. Genotype AA of ADRB2 gene is associated with reduced risks of the development of congenital defects of the tracheobronchial tree in BA. Polymorphic variants in the 4th and 6th exon of IL-33 gene are more frequently associated with moderate and severe course of asthma and base substitution in the 4th and 6th exon are associated with the severe course. Conclusions. Associations of polymorphic variants of HHIP, ADRB2 and IL-33 genes with clinical manifestations of BA in children are determined in this study. They can be considered in a personalized monitoring of the patients and can help to control the disease totally.
- Open Access
Association of Polymorphic Variants of HHIP, ADRB2 and IL-33 Genes with Clinical Manifestations of Bronchial Asthma in Children
Studying the contribution of genetic mechanisms to the development of bronchial asthma (BA) is to look for associations of the disease and its phenotypes with polymorphic markers of candidate genes. Objective: To investigate the association of polymorphic variants of HHIP, ADRB2 and IL-33 genes with the phenotypes of clinical course of BA in children and the effectiveness of therapy of the disease Patients and methods: A cohort single-center study of 90 bronchial asthma patients aged 5 to 17 years with an established diagnosis of bronchial asthma of varying degree of severity and control was conducted. The allele and genotype frequencies of polymorphic loci of the following genes were studied: rs12551256-A and rs146597587-G of IL-33 gene; rs12504628 of HHIP gene and ARG16GLY rs1042713 of ADRB2 gene in 90 BA patients with regard to the severity and control of the disease. In children with severe BA, as well as in children with poorly controlled/uncontrolled asthma (n=26), sequencing of the entire coding sequence of the IL-33 gene located on the 9th chromosome in the 9p24.1 region was additionally performed (search for mutations in 9 exons). Results: Comparison of genetic markers in patients with severe BA (tBA) and non-severe BA (nBA) revealed a reduced risk of severe disease realization among those carrying the TT genotype (OR=0.221 (95% CI: 0.059-0.828; χ2=5.759; p=0.056)) and the T allele (OR=0.491 (95% CI: 0.190-1.269; χ2=4.270; p=0.039)) of the studied genetic variant rs12504628 (T>C) of the HHIP gene, the frequency of the CC genotype in severe BA was 64%, versus 28% in nonsevere BA, and the C allele 77% versus 52%.Comparison of genetic markers in patients with a combination of atopic dermatitis (AtD) and bronchial asthma (BA+AtD) and BA without AtD (BA without AtD) revealed an increased risk of combining asthma and dermatitis among individuals carrying the TT genotype (OR=2.875 (95% CI: 1.130-7.316; χ2=5.751; p=0.056)) of genetic variant rs12504628 (T>C) of the HHIP gene. Sequencing and exome analysis of the IL-33 gene showed a statistically significant positive association between the frequency of lesions in exons 4 (r=0.417; p=0.034) and 6 (r=0.593; p=0.001) on the one hand and the severity of BA on the other. Nucleotide substitutions in these exons were found to be more frequently associated with the severe course of bronchial asthma. Conclusion: It was shown that TT genotype of genetic variant rs12504628 (T>C) of HHIP gene reduces the risk of severe BA, but increases the risk of atopic dermatitis combined with BA by 2.8 times. The CC+ST genotype of the HHIP gene increases the risk of drug allergy against the background of BA by 2.9 times. Polymorphic variants in exons 4 and 6 of the IL-33 gene are more often combined with moderate and severe asthma, and nucleotide substitutions in exons 4 and 6 are associated with a severe course of BA.
Open AccessAssociation of Polymorphic Variants of HHIP, ADRB2 and IL-33 Genes with Clinical Manifestations of Bronchial Asthma in Children
Studying the contribution of genetic mechanisms to the development of bronchial asthma (BA) is to look for associations of the disease and its phenotypes with polymorphic markers of candidate genes. Objective: To investigate the association of polymorphic variants of HHIP, ADRB2 and IL-33 genes with the phenotypes of clinical course of BA in children and the effectiveness of therapy of the disease Patients and methods: A cohort single-center study of 90 bronchial asthma patients aged 5 to 17 years with an established diagnosis of bronchial asthma of varying degree of severity and control was conducted. The allele and genotype frequencies of polymorphic loci of the following genes were studied: rs12551256-A and rs146597587-G of IL-33 gene; rs12504628 of HHIP gene and ARG16GLY rs1042713 of ADRB2 gene in 90 BA patients with regard to the severity and control of the disease. In children with severe BA, as well as in children with poorly controlled/uncontrolled asthma (n=26), sequencing of the entire coding sequence of the IL-33 gene located on the 9th chromosome in the 9p24.1 region was additionally performed (search for mutations in 9 exons). Results: Comparison of genetic markers in patients with severe BA (tBA) and non-severe BA (nBA) revealed a reduced risk of severe disease realization among those carrying the TT genotype (OR=0.221 (95% CI: 0.059-0.828; χ2=5.759; p=0.056)) and the T allele (OR=0.491 (95% CI: 0.190-1.269; χ2=4.270; p=0.039)) of the studied genetic variant rs12504628 (T>C) of the HHIP gene, the frequency of the CC genotype in severe BA was 64%, versus 28% in nonsevere BA, and the C allele 77% versus 52%.Comparison of genetic markers in patients with a combination of atopic dermatitis (AtD) and bronchial asthma (BA+AtD) and BA without AtD (BA without AtD) revealed an increased risk of combining asthma and dermatitis among individuals carrying the TT genotype (OR=2.875 (95% CI: 1.130-7.316; χ2=5.751; p=0.056)) of genetic variant rs12504628 (T>C) of the HHIP gene. Sequencing and exome analysis of the IL-33 gene showed a statistically significant positive association between the frequency of lesions in exons 4 (r=0.417; p=0.034) and 6 (r=0.593; p=0.001) on the one hand and the severity of BA on the other. Nucleotide substitutions in these exons were found to be more frequently associated with the severe course of bronchial asthma. Conclusion: It was shown that TT genotype of genetic variant rs12504628 (T>C) of HHIP gene reduces the risk of severe BA, but increases the risk of atopic dermatitis combined with BA by 2.8 times. The CC+ST genotype of the HHIP gene increases the risk of drug allergy against the background of BA by 2.9 times. Polymorphic variants in exons 4 and 6 of the IL-33 gene are more often combined with moderate and severe asthma, and nucleotide substitutions in exons 4 and 6 are associated with a severe course of BA.
- Open Access
- 28 February 2009
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- No. 1,p. 55-58-58
Lung function assessment using the interrupter technique in infants and preschool children
Несмотря на пристальное изучение новых методов оценки функции внешнего дыхания (ФВД) у детей в раннем и дошкольном возрасте, именно у детей первых 4 лет возникают наибольшие сложности исследования вентиляционной функции. В связи с этим несомненна актуальность исследования, касающегося диагностических возможностей метода кратковременного прерывания потока воздуха в педиатрической практике. В статье приводятся результаты оценки ФВД данным методом у больных бронхиальной астмой, атопическим дерматитом, острым бронхитом, острым стенозирующим ларинготрахеитом и у здоровых детей раннего и дошкольного возраста. Обсуждаются результаты математического моделирования показателя сопротивления дыхательных путей.
- 28 February 2009
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- No. 1,p. 55-58-58
Open AccessLung function assessment using the interrupter technique in infants and preschool children
Несмотря на пристальное изучение новых методов оценки функции внешнего дыхания (ФВД) у детей в раннем и дошкольном возрасте, именно у детей первых 4 лет возникают наибольшие сложности исследования вентиляционной функции. В связи с этим несомненна актуальность исследования, касающегося диагностических возможностей метода кратковременного прерывания потока воздуха в педиатрической практике. В статье приводятся результаты оценки ФВД данным методом у больных бронхиальной астмой, атопическим дерматитом, острым бронхитом, острым стенозирующим ларинготрахеитом и у здоровых детей раннего и дошкольного возраста. Обсуждаются результаты математического моделирования показателя сопротивления дыхательных путей.